REQUEST A DEMO
Total
USD $0.00
Search more companies

Chiral Drugs Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chiral Drugs Pvt Ltd Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Chiral Drugs Pvt Ltd is based in India. The head office is in Surat. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on October 19, 1995. Chiral Drugs Pvt Ltd currently employs 20 (2024) people. In its most recent financial highlights, the company reported a net sales revenue drop of 34.93% in 2024. There was a total negative growth of 24.85% in Chiral Drugs Pvt Ltd’s total assets over the same period. Chiral Drugs Pvt Ltd’s net profit margin decreased by 1.46% in 2024.

Legal Address
Plot No. 284, Road No. 2 Sachin Gidc
Surat; Gujarat; Postal Code: 394230

Contact Details: Purchase the Chiral Drugs Pvt Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Chiral Drugs Pvt Ltd report to view the information.
Registered Capital:
Purchase the Chiral Drugs Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Chiral Drugs Pvt Ltd report to view the information.
Incorporation Date:
October 19, 1995
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Chiral Drugs Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-34.93%
Total Operating Revenue
-35.37%
Operating Profit
-52.62%
EBITDA
-17.44%
Net Profit/Loss for the Period
-88.76%
Total Assets
-24.85%
Total Equity
5.22%
Operating Profit Margin
-1.48%
Net Profit Margin
-1.46%
Return on Equity (ROE)
-41.47%
Debt / Equity
-13.37%
Quick Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?